ArticleThe pharmacogenomics journal2014

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.

T Winder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.